Effectiveness of phosphodiesterase type 5 inhibitors on the treatment of thin endometrium and pregnancy outcomes: An systematic review

Farnoosh Farahbod; Parham Talebi-Boroujeni; Catherine M.T. Sherwin; Saeid Heidari-Soureshjani

doi:10.1177/22840265221094405

Effectiveness of phosphodiesterase type 5 inhibitors on the treatment of thin endometrium and pregnancy outcomes: An systematic review

Farnoosh Farahbod, Parham Talebi-Boroujeni, Catherine M.T. Sherwin, Saeid Heidari-Soureshjani

Wright State University

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	132-142
Number of pages	11
Journal	Journal of Endometriosis and Pelvic Pain Disorders
Volume	14
Issue number	3
DOIs	https://doi.org/10.1177/22840265221094405
State	Published - Sep 1 2022

ASJC Scopus Subject Areas

Obstetrics and Gynecology

Keywords

endometrium
Phosphodiesterase type 5 inhibitors
pregnancy outcome
sildenafil citrate
tadalafil
Phosphodiesterase inhibitors
letrozole
pregnancy outcomes
vascular endothelial growth factors
vascular smooth muscle

Disciplines

Medical Specialties
Medicine and Health Sciences
Pediatrics

Access to Document

10.1177/22840265221094405

Cite this

Effectiveness of phosphodiesterase type 5 inhibitors on the treatment of thin endometrium and pregnancy outcomes: An systematic review. / Farahbod, Farnoosh; Talebi-Boroujeni, Parham; Sherwin, Catherine M.T. et al.
In: Journal of Endometriosis and Pelvic Pain Disorders, Vol. 14, No. 3, 01.09.2022, p. 132-142.

Research output: Contribution to journal › Review article › peer-review

@article{df2fa485d54e4b29b9d95670af7988a5,

title = "Effectiveness of phosphodiesterase type 5 inhibitors on the treatment of thin endometrium and pregnancy outcomes: An systematic review",

keywords = "endometrium, Phosphodiesterase type 5 inhibitors, pregnancy outcome, sildenafil citrate, tadalafil, Phosphodiesterase inhibitors, letrozole, pregnancy outcomes, vascular endothelial growth factors, vascular smooth muscle",

author = "Farnoosh Farahbod and Parham Talebi-Boroujeni and Sherwin, {Catherine M.T.} and Saeid Heidari-Soureshjani",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2022.",

year = "2022",

month = sep,

day = "1",

doi = "10.1177/22840265221094405",

language = "English",

volume = "14",

pages = "132--142",

journal = "Journal of Endometriosis and Pelvic Pain Disorders",

issn = "2284-0265",

number = "3",

}

TY - JOUR

T1 - Effectiveness of phosphodiesterase type 5 inhibitors on the treatment of thin endometrium and pregnancy outcomes

T2 - An systematic review

AU - Farahbod, Farnoosh

AU - Talebi-Boroujeni, Parham

AU - Sherwin, Catherine M.T.

AU - Heidari-Soureshjani, Saeid

N1 - Publisher Copyright: © The Author(s) 2022.

PY - 2022/9/1

Y1 - 2022/9/1

KW - endometrium

KW - Phosphodiesterase type 5 inhibitors

KW - pregnancy outcome

KW - sildenafil citrate

KW - tadalafil

KW - Phosphodiesterase inhibitors

KW - letrozole

KW - pregnancy outcomes

KW - vascular endothelial growth factors

KW - vascular smooth muscle

UR - http://www.scopus.com/inward/record.url?scp=85130604480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85130604480&partnerID=8YFLogxK

UR - https://corescholar.libraries.wright.edu/pediatrics/656

U2 - 10.1177/22840265221094405

DO - 10.1177/22840265221094405

M3 - Review article

AN - SCOPUS:85130604480

SN - 2284-0265

VL - 14

SP - 132

EP - 142

JO - Journal of Endometriosis and Pelvic Pain Disorders

JF - Journal of Endometriosis and Pelvic Pain Disorders

IS - 3

ER -

Effectiveness of phosphodiesterase type 5 inhibitors on the treatment of thin endometrium and pregnancy outcomes: An systematic review

ASJC Scopus Subject Areas

Keywords

Disciplines

Access to Document

Other files and links

Cite this